Evidence map›Paper›PMID 35218366›Full record

ArticleIntensive care medicine2022

Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19.

Bertrand Guidet, Christian Jung, Hans Flaatten, Jesper Fjølner, Antonio Artigas, Bernardo Bollen Pinto, Joerg C Schefold, Michael Beil, Sviri Sigal, Peter Vernon van Heerden and 12 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Intensive care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 47 citations in OpenAlex.

  1. Comparative analysis of COVID-19 critically ill patients across four pandemic waves in Greece.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 19 institutions in 16 countries.

Bertrand GuidetUPMC Univ Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: épidémiologie hospitalière qualité et organisation des soins, Medical Intensive Care, Sorbonne Universités, 184 rue du Faubourg Saint Antoine, 75012, Paris, France. bertrand.guidet@aphp.fr.ORCID http://orcid.org/0000-0002-7643-6770
Christian JungDepartment of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.
Hans FlaattenDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Jesper FjølnerDepartment of Intensive Care, Aarhus University Hospital, Aarhus, Denmark.
Antonio ArtigasDepartment of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain.
Bernardo Bollen PintoDepartment of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.
Joerg C SchefoldDepartment of Intensive Care Medicine, Inselspital, Universitätsspital, University of Bern, Bern, Switzerland.
Michael BeilMedical Intensive Care, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Sviri SigalMedical Intensive Care, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Peter Vernon van HeerdenGeneral Intensive Care, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Wojciech SzczeklikCenter for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland.
Michael JoannidisDivision of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.
Sandra OeyenDepartment of Intensive Care 1K12IC, Ghent University Hospital, Ghent, Belgium.
Eumorfia KondiliIntensive Care Unit, University Hospital of Heraklion, Medical School University of Crete, Giofirakia, Greece.
Brian MarshMater Misericordiae University Hospital, Dublin, Ireland.
Finn H AndersenDepartment of Anaesthesia and Intensive Care, Ålesund Hospital, Alesund, Norway.
Rui MorenoCentro Hospitalar Universitário de Lisboa Central, Faculdade de Ciências Médicas de Lisboa, Nova Médical School, Unidade de Cuidados Intensivos Neurocríticos e Trauma. Hospital de São José, Lisbon, Portugal.
Maurizio CecconiDepartment of Anaesthesia IRCCS, Instituto Clínico Humanitas, Humanitas University, Milan, Italy.
Susannah LeaverGeneral Intensive Care, St George's University Hospitals NHS Foundation Trust, London, UK.
Dylan W De LangeDepartment of Intensive Care Medicine, University Medical Center, University Utrecht, Utrecht, the Netherlands.
Ariane BoumendilUPMC Univ Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: épidémiologie hospitalière qualité et organisation des soins, Medical Intensive Care, Sorbonne Universités, 184 rue du Faubourg Saint Antoine, 75012, Paris, France.
VIP2 and COVIP study groups
Innsbruck Medical University · ATHebrew University of Jerusalem · ILNorwegian University of Science and Technology · NOAarhus University Hospital · DKGhent University Hospital · BEInserm · FRMater Misericordiae University Hospital · IESorbonne Université · FRSt George’s University Hospitals NHS Foundation Trust · GBUniversity Medical Center Utrecht · NLUniversity of Bern · CHHeinrich Heine University Düsseldorf · DEHospital de São José · PTUniversity Hospital of Geneva · CHHaukeland University Hospital · NOHumanitas University · ITJagiellonian University · PLUniversitat Autònoma de Barcelona · ESUniversity of Crete · GR

Funding

Horizon 2020 831644Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf 2020-21
6 · The paper itself

Abstract

purposeThe number of patients ≥ 80 years admitted into critical care is increasing. Coronavirus disease 2019 (COVID-19) added another challenge for clinical decisions for both admission and limitation of life-sustaining treatments (LLST). We aimed to compare the characteristics and mortality of very old critically ill patients with or without COVID-19 with a focus on LLST.

methodsPatients 80 years or older with acute respiratory failure were recruited from the VIP2 and COVIP studies. Baseline patient characteristics, interventions in intensive care unit (ICU) and outcomes (30-day survival) were recorded. COVID patients were matched to non-COVID patients based on the following factors: age (± 2 years), Sequential Organ Failure Assessment (SOFA) score (± 2 points), clinical frailty scale (± 1 point), gender and region on a 1:2 ratio. Specific ICU procedures and LLST were compared between the cohorts by means of cumulative incidence curves taking into account the competing risk of discharge and death.

results693 COVID patients were compared to 1393 non-COVID patients. COVID patients were younger, less frail, less severely ill with lower SOFA score, but were treated more often with invasive mechanical ventilation (MV) and had a lower 30-day survival. 404 COVID patients could be matched to 666 non-COVID patients. For COVID patients, withholding and withdrawing of LST were more frequent than for non-COVID and the 30-day survival was almost half compared to non-COVID patients.

conclusionVery old COVID patients have a different trajectory than non-COVID patients. Whether this finding is due to a decision policy with more active treatment limitation or to an inherent higher risk of death due to COVID-19 is unclear.

Indexed as

COVID-19Respiratory InsufficiencyCritical CareCritical IllnessHumansIntensive Care UnitsSARS-CoV-2COVIDIntensive careMortalityOld patientsTreatment limitation

Identifiers

PMID35218366
PMCPMC8881896
OpenAlexW4214519147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.